NCT06952712View on ClinicalTrials.gov

Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

1,300

Participants

Timeline

Start Date

May 7, 2025

Primary Completion Date

May 6, 2028

Study Completion Date

May 6, 2028

Conditions
Preeclampsia
Interventions
DRUG

Aspirin 100mg

Aspirin 100mg qn was started from 12-16 weeks of gestation and discontinued from 36+0-36+6 weeks of gestation

DRUG

Aspirin 150mg

Aspirin 150mg qn was started from 12-16 weeks of gestation and discontinued from 36+0-36+6 weeks of gestation

Trial Locations (1)

510150

Fang He, Guangzhou

All Listed Sponsors
lead

FANG HE

OTHER